Extracting Semantic Predications from Medline Citations for Pharmacogenomics
By Caroline B. Ahlers, Marcelo Fiszman, Dina Demner-Fushman, François-Michel Lang, Thomas C. Rindflesch. 2006
114 citations recorded by the source corpus.
Subfields: Artificial Intelligence, Genetics, Molecular Biology
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Artificial Intelligence
In Genetics
- Yuan Luo
- Yael Garten
- Russ B. Altman
- Hong Yu
- Pierre Zweigenbaum
- Dina Demner-Fushman
- K. Cohen
- Junichi Tsujii
In Molecular Biology
Citations in the corpus
- Natural Language Processing for EHR-Based Computational Phenotyping (2018, background): “Computational phenotyping applications have been developed to mine pharmacogenomics knowledge [56-59].”
- Frontiers of biomedical text mining: current progress (2007, background): “addresses various kinds of relations, including genes/ proteins, protein point mutations [42], protein binding sites [43], gene-disease [44], phenotypic context [45, 46] and mutations [47].”
- An overview of MetaMap: historical perspective and recent advances (2010, methodology): “After some experience with MetaMap, it became clear that it could be applied to tasks other than retrieval, namely text mining,”
- Corpus annotation for mining biomedical events from literature (2008, methodology): “We will make the annotation results available to the community, and it is reasonable to expect that the corpus will contribute to further progress in NLP-based TM techniques, including event or relation extraction [57-59], intelligent information retrieval [13,60], semantic enrichment of text [61], ”
- Pharmspresso: a text mining tool for extraction of pharmacogenomic concepts and relationships from full text (2009, methodology): “Natural language processing has been applied to pharmacogenomics in the past [1,2], but there is an opportunity now to use it for extracting the connections between the entities of interest in pharma-cogenomics.”